Travelers (TRV) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

21.01.26 22:30 Uhr

Werte in diesem Artikel
Aktien

233,30 EUR 2,90 EUR 1,26%

Indizes

PKT PKT

49.077,2 PKT 588,6 PKT 1,21%

6.875,6 PKT 78,8 PKT 1,16%

Travelers (TRV) reported $12.45 billion in revenue for the quarter ended December 2025, representing a year-over-year increase of 3.2%. EPS of $11.13 for the same period compares to $9.15 a year ago.The reported revenue represents a surprise of +0.3% over the Zacks Consensus Estimate of $12.42 billion. With the consensus EPS estimate being $8.45, the EPS surprise was +31.72%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Travelers performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Combined Ratio - Consolidated: 80.2% versus the eight-analyst average estimate of 87%.Loss and loss adjustment expense ratio - Consolidated: 51.8% compared to the 58.4% average estimate based on eight analysts.Underwriting Expense Ratio - Consolidated: 28.4% compared to the 28.6% average estimate based on eight analysts.Loss and loss adjustment expense ratio - Business Insurance: 55.1% compared to the 59.9% average estimate based on seven analysts.Total Revenues- Net investment income: $1.05 billion versus the eight-analyst average estimate of $1.05 billion. The reported number represents a year-over-year change of +10.4%.Total Revenues- Fee income: $125 million versus $128.52 million estimated by eight analysts on average. Compared to the year-ago quarter, this number represents a -2.3% change.Total Revenues- Premiums: $11.15 billion versus $11.12 billion estimated by eight analysts on average. Compared to the year-ago quarter, this number represents a +2.6% change.Total Revenues- Other Revenues: $125 million versus $117.76 million estimated by eight analysts on average. Compared to the year-ago quarter, this number represents a +11.6% change.Revenues- Premiums- Business Insurance: $5.7 billion versus the seven-analyst average estimate of $5.66 billion. The reported number represents a year-over-year change of +2.9%.Revenues- Premiums- Personal Insurance: $4.4 billion versus the seven-analyst average estimate of $4.41 billion. The reported number represents a year-over-year change of +2%.Revenues- Premiums- Bond & Specialty Insurance: $1.05 billion compared to the $1.05 billion average estimate based on seven analysts. The reported number represents a change of +3.3% year over year.Revenues- Other revenues- Personal Insurance: $26 million versus $26.59 million estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +4% change.View all Key Company Metrics for Travelers here>>>Shares of Travelers have returned -7.8% over the past month versus the Zacks S&P 500 composite's -0.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Zacks' Research Chief Picks Stock Most Likely to "At Least Double"Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.See Our Top Stock to Double (Plus 4 Runners Up) >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report The Travelers Companies, Inc. (TRV): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Travelers und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Q4

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Q4

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Travelers Inc (Travelers Companies)

Wer­bung

Analysen zu Travelers Inc (Travelers Companies)

DatumRatingAnalyst
27.06.2019Travelers SellDeutsche Bank AG
19.04.2019Travelers Sector PerformRBC Capital Markets
09.01.2019Travelers OverweightBarclays Capital
24.04.2017Travelers BuyArgus Research Company
13.02.2017Travelers Companies Mkt PerformFBR & Co.
DatumRatingAnalyst
09.01.2019Travelers OverweightBarclays Capital
24.04.2017Travelers BuyArgus Research Company
16.12.2016Travelers Companies OutperformBMO Capital Markets
22.04.2016Travelers Companies OutperformRBC Capital Markets
22.01.2016Travelers Companies OutperformRBC Capital Markets
DatumRatingAnalyst
19.04.2019Travelers Sector PerformRBC Capital Markets
13.02.2017Travelers Companies Mkt PerformFBR & Co.
27.01.2016Travelers Companies NeutralUBS AG
23.01.2015Travelers Companies NeutralMKM Partners
06.01.2015Travelers Companies Mkt PerformFBR Capital
DatumRatingAnalyst
27.06.2019Travelers SellDeutsche Bank AG

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Travelers Inc (Travelers Companies) nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen